Cell adhesion has a fundamental role in the proliferation and motility of normal cells and the metastasis of tumor cells. To identify signaling pathways activated by the adherence of tumor cells, we analyzed the tyrosine phosphorylation of proteins in mouse melanoma cells before and after attachment to substrata. We discovered that cellular adherence activated the protein-tyrosine kinase of the cell surface receptor Met, whose ligand is hepatocyte growth factor and scatter factor. The activation was exceedingly prompt, affected the great majority of Met in the cells, persisted so long as the cells remained adherent, and was rapidly reversed as soon as the cells were detached from substrata. Activation of Met required that cells be adherent but not that they spread on the substratum, and it occurred in the absence of any apparent ligand for the receptor. Ligand-independent activation of Met occurred in several varieties of tumor cells but not in normal endothelial cells that express the receptor. The activation of Met described here may represent a means by which cells respond to mechanical as opposed to biochemical stimuli.
The adherence of cells to a substratum elicits a multitude of intracellular events. These events occur in response to signals that originate at the surface of the cell and are then propagated by diverse biochemical pathways (1, 2) . The details of this propagation and the means by which it elicits phenotypic responses remain largely obscure.
The ability of cells to adhere to specific surfaces is vital in the process of tumor metastasis (3, 4) . We hypothesized that the signaling response to cellular adherence might vary as a function of metastatic ability. To explore this possibility, we turned to variants of the B16 line of mouse melanoma cells. The F10 variant of these cells is highly metastatic to the lung when injected into a tail vein of mice, whereas the Fl variant is poorly metastatic (5, 6) .
As a first step in exploring signaling within the Fl and F10 variants, we analyzed the phosphorylation of proteins on tyrosine. We detected no substantive difference between the variants. Instead, we were led to the unanticipated finding that attachment of either Fl or F10 cells to substrata activated the protein-tyrosine kinase of a cell-surface receptor known as Met. The activation of Met required that the B16 cells be adherent but not that they spread on the substratum, and it occurred in the absence of any apparent ligand for the receptor.
Met is a heterodimer encoded by the protooncogene MET (7) . The gene gives rise to a single 170-kDa polypeptide that is then cleaved into a and ( subunits (45 kDa and 150 kDa, respectively). The two subunits remain joined by disulfide bonds. The a subunit is exclusively extracellular, whereas the (3 subunit crosses the plasma membrane and has an intracellular domain that carries protein-tyrosine kinase activity. The established ligand for Met is a polypeptide known as both hepatocyte growth factor and scatter factor (HGF-SF) (8, 9) . Binding of the ligand activates the Met kinase, apparently by eliciting dimerization of the f3 subunits and consequent autophosphorylation (10) . The eventual cellular responses can include mitogenesis, motility, and invasiveness (11) (12) (13) (14) . It has been reported previously that Met can also be active in the absence of HGF-SF (15) (16) (17) . We now show that this ligand-independent activity is elicited by the mere attachment of cells to substratum. Thus, Met can be activated by a means other than binding to the conventional ligand. Ligandindependent activation of the ,B receptor for platelet-derived growth factor has also been reported recently (18) , although the requirements for that activation differ appreciably from those reported here for Met. In aggregate, these findings raise the possibility that previously unappreciated mechanisms can activate signaling from at least some transmembrane receptors, perhaps to inform the interior of the cell that a mechanical event has affected the cell.
MATERIALS AND METHODS
Cells. The B16F10 murine melanoma cell line was obtained from the Division of Cancer Treatment Tumor Bank, National Cancer Institute-Frederick Cancer Research Facility (Frederick, MD). HT144 human melanoma and HT29 and HCT116 human colon carcinoma cell lines were from the American Type Culture Collection. HUVEC, human umbilical vein endothelial cells, were obtained from Clonetics. BBE, bovine brain capillary endothelial cells, were provided by R. I. Weiner (University of California, San Francisco).
Immunoprecipitation and Immunoblotting. Anti-phosphotyrosine monoclonal antibody 4G10 was provided by D. Morrison, B. Drunker, and T. Roberts (National Cancer Institute, Frederick, MD). Anti-Met antibody, a rabbit polyclonal antipeptide antibody raised against murine Met, was from Santa Cruz Biotechnology. Anti-Fak antibody, a rabbit polyclonal antibody raised against chicken Fak and crossreacting with murine Fak, was from Upstate Biotechnology (Lake Placid, NY).
Tumor cells were starved in serum-free media supplemented with 1% bovine serum albumin for 18-24 hr before experiments. Lysis of cells and immunoblotting were performed as described (19) tTo whom reprint requests should be addressed.
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Tris-HCl (pH 7.5), 10 mM phosphorylated in either setting. The specificity of the antisera for Met-P precluded detection of the a-subunit in these analyses.
We found further examples of tyrosine phosphorylation of Met in other lines of tumor cells that express the receptor (although there was one exception, the HT144 line of human melanoma cells) ( Table 1) . In every instance, the phosphorylation disappeared when the cells were detached from the substratum (data not shown). In contrast, no tyrosine phosphorylation of Met was observed in cultures of normal endothelial cells that express Met (Table 1) .
When we began this study, we anticipated that variations in the capacity to metastasize might be accompanied by variations in the signaling response to cellular adhesion. In the one comparison that we have made, however, this expectation was not fulfilled; Met-,B was equally phosphorylated in both the Fl and F10 variants of B16 melanoma cells (Table 1 and data not shown), despite the large difference in their ability to metastasize (5, 6).
The Protein-Tyrosine Kinase of Met-.8 Is Active in Adherent but not Suspended Cells. Met-83 carries the protein-tyrosine kinase activity of the Met receptor (7, 10) . Activation of this kinase might well account for phosphorylation of the subunit in attached cells. We explored this possibility with an immune- Proc. Natl. Acad. Sci. USA 93 (1996) Met-13 was apparent in the fraction of newly adherent cells within one minute and reached a maximum by 30 min (Fig.  3A) . Met accumulation reflects the number of cells that adhered. The appearance of phosphorylated Met followed a closely similar time course and then persisted without apparent diminution for as long as the cells remained adherent (Fig. 3A and data not shown). The persistence of the phosphorylation is in accord with our previous finding that the activation of Met-f3 kinase and the consequent autophosphorylation are apparently constitutive events in adherent B16F10 cells (see above).
When analyzed quantitatively (Fig. 3B) , the adherence of cells, the accumulation of Met, and the appearance of tyrosinephosphorylated Met all followed the same time course. We conclude that activation of Met-,B kinase and autophosphorylation of the protein must occur without appreciable delay following adherence of the cells.
We also attempted to assess how rapidly Met-j3 was dephosphorylated following detachment from substratum. When the initial immunoprecipitation was performed with an antibody against phosphotyrosine, it appeared that the bulk of the detectable Met-13 was recovered (Fig. 4 Upper, compare lanes 1 and 2). In accord with this conclusion, the supernatant remaining after precipitation with antibody against phosphotyrosine contained only a small residue of Met, which was feebly phosphorylated on tyrosine (Fig. 4, lane 3) . We conclude that tyrosine phosphorylation affects the great majority of Met-, molecules in adherent B16F10 cells. As before, phosphorylation of the 170-kDa Met precursor was virtually undetectable (Fig. 4 (26) . Under these conditions, the melanoma cells attached firmly to the substratum but failed to spread (Fig. SA) . The failure to spread in the presence of cytochalasin D had no effect on the tyrosine phosphorylation of Met-,3 (Fig. SB Upper) . Thus, it appeared that adherence alone was sufficient to activate the Met receptor.
In an effort to affirm this conclusion, we plated cells on a variety of substrata. These included poly-L-lysine, on which the B16F10 cells adhered but did not spread; and fibronectin, and type IV collagen, on which the cells both adhered and spread. Tyrosine phosphorylation of Met-,B was the same in all of these settings (data not shown). We again concluded that cellular adherence alone was sufficient for activation of the Met receptor.
The Fak kinase is found in focal adhesions, where it apparently participates in signaling after the adherence and spreading of cells (21) (22) (23) (Fig. 6) . In addition, serum-free medium exposed to adherent B16F10 cells for 8 hr Proc. Natl. Acad. Sci. USA 93 (1996) described the ligand-independent activation of the plateletderived growth factor /3-receptor in response to cell adhesion and spreading, distortion of cell shape and external strain (18) . The activation superficially resembled that described here for Met, but there were notable differences as well. In particular, the ligand-independent activation of the platelet-derived growth factor 3-receptor was not elicited by cell attachment alone, requiring both adherence and spreading, and it was accompanied by activation of Fak. Several previous reports have implicated the activity of Met in tumorigenicity and metastasis, by virtue of its ability to elicit mitosis, motility, invasiveness and angiogenesis (14, (27) (28) (29) . We failed to find any evidence that the ligand-independent activation of Met correlated with the metastatic capability of tumor cells. But we have examined only one pair of metastatic variants, and the assay by which their metastatic potential was determined may not be sensitive to the role of Met. Mitogenesis and motogenesis are also prominent cellular responses to the activation of Met by HGF-SF. We have no evidence that the ligand-independent activation of Met described here elicits either of these responses, but the matter requires further study.
